Table 4.
Association between elevated or change in hs-cTnT and in-hospital mortality, univariate and multivariate logistic regression analysis
| p value | Unadjusted OR (95% CI) | P value | Adjusted OR (95% CI) (1) | |
|---|---|---|---|---|
| hs-cTnT > 14 ng/L |
0.174 |
2.10 (0.72–6.12) |
0.839 |
1.15 (0.17–4.22) |
| log hs-cTnT |
0.132 |
1.51 (0.88–2.59) |
0.668 |
1.21 (0.51–2.89) |
| δ hs-cTnT ≥ 20% (2) |
0.011 |
4.90 (1.43–16.79) |
0.026 |
5.35 (1.22–23.54) |
| δ hs-cTnT ≥ 9.2 ng/L (2) | 0.007 | 4.78 (1.53–14.96) | 0.032 | 4.77 (1.15–19.86) |
(1) Adjusted for: age ≥ 76 years, gender, stroke severity (NIHSS), coronary heart disease, cerebrovascular disease, atrial fibrillation, smoking, hypertension, diabetes mellitus, eGFR.
(2) Rise or fall with at least one value above the 99th percentile of the upper reference limit (>14 ng/L).
eGFR: estimated glomerular filtration rate; hs-cTnT: high sensitivity cardiac troponin T; NIHSS: National Institutes of Health Stroke Scale.